Published in Cancer Control on October 01, 2009
Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators. Psychooncology (2010) 0.98
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care. J Oncol Pract (2011) 0.96
Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care. J Oncol Pract (2012) 0.89
If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records. J Oncol Pract (2014) 0.88
Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval. J Am Coll Surg (2013) 0.81
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida. J Oncol Pract (2011) 0.81
Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval. J Am Coll Surg (2014) 0.80
Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open (2013) 0.80
Implementation of a performance improvement initiative in colorectal cancer care. J Oncol Pract (2012) 0.75
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval. J Oncol Pract (2014) 0.75
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med (2002) 4.75
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet (2011) 4.70
NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev (2008) 3.93
The accuracy of noninvasive hemoglobin monitoring using the radical-7 pulse CO-Oximeter in children undergoing neurosurgery. Anesth Analg (2012) 3.71
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell (2012) 3.21
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res (2005) 3.08
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res (2006) 3.00
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin Cancer Res (2006) 2.68
Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis (2008) 2.56
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol (2002) 2.51
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine (2011) 2.43
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 2.41
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33
Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol (2009) 2.31
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clin Cancer Res (2007) 2.28
Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med (2011) 2.21
Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res (2010) 2.19
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res (2006) 2.11
Exertional desaturation as a predictor of rapid lung function decline in COPD. Respiration (2012) 2.09
Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage (2004) 2.07
Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer (2009) 2.01
Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology (2009) 1.80
Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer (2005) 1.65
Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet (2012) 1.64
Suicide in patients with pancreatic cancer. Cancer (2010) 1.62
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. J Clin Oncol (2008) 1.61
Colon cancer, version 3.2014. J Natl Compr Canc Netw (2014) 1.59
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55
Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology (2008) 1.52
Primary care utilization and colorectal cancer incidence and mortality among Medicare beneficiaries: a population-based, case-control study. Ann Intern Med (2013) 1.51
Sun protection at elementary schools: a cluster randomized trial. J Natl Cancer Inst (2010) 1.50
Investigating the role of appearance-based factors in predicting sunbathing and tanning salon use. J Behav Med (2009) 1.49
Rectal cancer. J Natl Compr Canc Netw (2012) 1.49
Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol (2005) 1.48
Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage (2004) 1.48
Functional impairment and the economic consequences of female breast cancer. Women Health (2002) 1.47
Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol (2005) 1.47
Proteomic contributions to personalized cancer care. Mol Cell Proteomics (2008) 1.46
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev (2006) 1.45
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer (2005) 1.44
Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology (2006) 1.44
Magnetic ratchet for three-dimensional spintronic memory and logic. Nature (2013) 1.44
Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene (2002) 1.39
Optimal Chest Compression Position for Patients With a Single Ventricle During Cardiopulmonary Resuscitation. Pediatr Crit Care Med (2016) 1.38
Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys (2009) 1.38
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res (2007) 1.37
Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev (2011) 1.37
A randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med (2004) 1.37
Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res (2002) 1.37
Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol (2010) 1.35
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.31
Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J (2008) 1.30
Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol (2007) 1.29
A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.28
Screening for psychological distress in cancer patients: challenges and opportunities. J Clin Oncol (2007) 1.27
Appearance reasons for tanning mediate the relationship between media influence and UV exposure and sun protection. Arch Dermatol (2006) 1.27
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Res (2013) 1.27
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med (2009) 1.26
Cancer-related fatigue. J Natl Compr Canc Netw (2010) 1.26
Appearance motives to tan and not tan: evidence for validity and reliability of a new scale. Ann Behav Med (2008) 1.25
Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg (2008) 1.25
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics Clin Appl (2011) 1.25
A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.25
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys (2009) 1.24
Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer (2010) 1.23
Long-term results from a randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med (2005) 1.23
Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol (2010) 1.22
Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology (2002) 1.21
Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage (2008) 1.21
Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer (2009) 1.20
Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry. J Proteome Res (2010) 1.20
Enhancing research on cancer survivors. J Clin Oncol (2006) 1.20
Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage (2002) 1.18
The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res (2003) 1.18
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.17
An investigation of appearance motives for tanning: The development and evaluation of the Physical Appearance Reasons For Tanning Scale (PARTS) and its relation to sunbathing and indoor tanning intentions. Body Image (2006) 1.16
Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer (2010) 1.16
Distress management. J Natl Compr Canc Netw (2013) 1.16
Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res (2002) 1.16
The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer (2010) 1.16
Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res (2002) 1.15
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res (2002) 1.13
Associations between pain and current smoking status among cancer patients. Pain (2011) 1.13
Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. Ann Surg Oncol (2006) 1.13
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer (2005) 1.12
Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats. Respirology (2010) 1.12
Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat (2002) 1.12
Human papillomavirus and molecular considerations for cancer risk. Cancer (2008) 1.12
Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manage (2008) 1.12
Strategies for assessing community challenges and strengths for cancer disparities participatory research and outreach. Health Promot Pract (2009) 1.12
Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum (2008) 1.12
Survivorship care planning in colorectal cancer: feedback from survivors & providers. J Psychosoc Oncol (2012) 1.11